Effective with date of service May 6, 2020, the Medicaid and NC Health Choice programs cover daratumumab and hyaluronidase-fihj injection, for subcutaneous use (Darzalex Faspro™) for use in the Physician Administered Drug Program (PADP) when billed with HCPCS code J9999 - Not otherwise classified, antineoplastic drugs.
Medicaid Bulletin
Medicaid Bulletin Monthly Digest
Articles beginning January 2018 are available in the blog format.
Effective July 1, 2020, coverage of therapeutic Continuous Glucose Monitoring (CGM) products is transitioning from the Durable Medical Equipment (DME) Program to the Outpatient Pharmacy Point of Sale (POS) Program.
This NC Medicaid Bulletin provides an overview of COVID-19 rate increases applicable to SNFs and Hospice providers; Hospice provider rate increase from 95% to 100% of Skilled Nursing Facility (SNF) reimbursement rates for room and board services provided in a SNF; and billing guidelines for Hospice services provided in a SNF designated as a “COVID-19 Outbreak” or “COVID-19 Response” site.
On July 17, 2020, the Centers for Medicare & Medicaid Services announced that the deadline for Medicaid/CHIP providers to submit their financial data to apply for federal Provider Relief Funds has been extended to Aug. 3, 2020.
The Centers for Medicare & Medicaid Services (CMS) recently approved North Carolina’s Medicaid Disaster 1115 Waiver. The waiver includes several provisions that allow flexibility for long-term services and supports (LTSS) to maintain services for beneficiaries and financial relief for home and community-based service (HCBS) providers.
North Carolina providers that participate in Medicaid may be eligible to receive federal relief as a result of lost revenue or new expenses relating to the COVID-19 Public Health Emergency.
Registration is open for the August 2020 NCTracks instructor-led provider training courses listed below. Slots are limited. WebEx courses can be attended remotely from any location with a telephone, computer and internet connection.
Effective July 1, 2020, End Stage Renal Disease (ESRD) Treatment providers (261QE0700X) were added to the list of eligible providers for Procedure Code J0887, Mircera, Injection, Epoetin Beta, 1 Microgram, (FOR ESRD ON DIALYSIS).
Effective Jan. 1, 2020, the title of Clinical Coverage Policy 1A-34 changed to Dialysis Services. In addition to the title change, the Division of Health Benefits will now cover services for Acute Kidney Injury (AKI).
Clinical Policy 1E-3, Sterilization Procedures, has been revised and will post Aug. 15, 2020 on the NC Medicaid website.